CASE COMMENT: RESTRICTIVE PRACTICES - ABUSE OF DOMINANCE - CARTEL - RESTRICTION - REFUSAL TO SELL FOR EXPORTATION PURPOSES - DRUGS SECTOR

Export restriction : Pharmaceutical laboratories do not abuse their dominant position when they restrict or refuse deliveries of medicines to exporters who seek to purchase products in France at a regulated price in order to resell them later on in another country at a higher price (Parallel export of drugs)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. On December 20, 2005, the Competition Council made public two decisions. If, in the first, Decision No. 05-D-70 of the 19 December 2005 on practices implemented in the sector pre-recorded videotapes, it penalizes the practices of vertical price agreements implemented by BVHE (Buena Vista Home Entertainment), the exclusive distributor of the Disney videotapes for France, and by the distributors Casino and Carrefour, as well as a wholesaler, in the second - the decision No. 05-D-72 of 20 December 2005, it relates to practices implemented by the work by various laboratories in the export sector parallel trade in medicinal products - Council decides to dismiss

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • L’actu-concurrence (Paris)

Quotation

Alain Ronzano, Export restriction : Pharmaceutical laboratories do not abuse their dominant position when they restrict or refuse deliveries of medicines to exporters who seek to purchase products in France at a regulated price in order to resell them later on in another country at a higher price (Parallel export of drugs), 20 December 2005, Concurrences N° 1-2006, Art. N° 55037, www.concurrences.com

Visites 155

All reviews